FIELD: medicine.
SUBSTANCE: invention is related to dermatovenereology and cosmetology, and can be used for prevention of retinoid dermatitis in patients with acne. Systemic isotretinoin is taken at a dose of 0.5 mg/kg until a course dose of 120 mg/kg body weight is reached, facial skin is cleansed with Vichy Purete Thermale foam in the morning and evening, after cleansing, Vichy Mineral 89 Probiotic Fractions restorative serum concentrate is applied and express mask Vichy Mineral 89 is used once every 10 days.
EFFECT: method allows for prevention and relief of retinoid dermatitis and side effects such as dryness and irritation of the facial skin, by expanding the arsenal of products for external use for dry and stressed skin in patients with acne receiving a course of systemic isotretinoin.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THE TREATMENT OF SEVERE ACNE ON THE BACKGROUND OF CHRONIC OPISTHORCHIASIS | 2021 |
|
RU2769318C1 |
METHOD FOR COMBINED TREATMENT OF SEVERE ACNE | 2019 |
|
RU2713938C1 |
DEVICE AND METHOD FOR LOCAL TREATMENT OF PAPULO-PAPULOPUSTULAR SHAPE ROSACEA | 2014 |
|
RU2583559C2 |
METHOD OF TREATING ACNE (VERSIONS) | 2023 |
|
RU2822952C1 |
METHOD OF COMBINED EXTERNAL THERAPY OF ERYTHEMATOUS-PAPULAR ROSACEA | 2019 |
|
RU2697854C1 |
METHOD OF TREATING ACNE | 2017 |
|
RU2674981C1 |
METHOD OF TREATING EXCHORINATED ACNE | 2018 |
|
RU2699061C1 |
METHOD FOR OUTPATIENT TREATMENT OF FACIAL SKIN OF PATIENTS WITH ROSACEA | 2015 |
|
RU2577297C1 |
METHOD OF LOCAL TREATMENT OF FACIAL PAPULOPUSTULAR DERMATOSES | 2022 |
|
RU2790768C1 |
METHOD OF TREATING CHRONIC OPISTHORCHIASIS IN PATIENTS WITH ROSACEA | 2014 |
|
RU2556962C1 |
Authors
Dates
2023-09-26—Published
2022-12-26—Filed